SCHEMBL3130176

SCHEMBL3130176

CC1(C)O[C@@]23CC[C@@]4(C)[C@@](O)(CCC5Cc6c([nH]c7ccccc67)[C@@]54C)C2=CC(=O)[C@@H]1O3

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 5/20 0.57
MAPT P10636 3/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
ALOX15 P16050 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
ATP2A2 P16615 1/20 0.55
HTT P42858 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
ATP2A3 Q93084 1/20 0.55
PGR P06401 2/20 0.52
PTPRS Q13332 1/20 0.47
PTPN2 P17706 3/20 0.42
KIF11 P52732 3/20 0.41
CNR1 P21554 2/20 0.38
CNR2 P34972 2/20 0.38
GPR18 Q14330 2/20 0.38
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Paxilline SCHEMBL20857134 0.88 MAPT (0.78) PTPN1MAPTMEN1KMT2ACYP1A2
SCHEMBL13883377 0.87 PGR (0.48) PTPN1MAPTMEN1KMT2ACYP1A2
SCHEMBL13883004 0.87 PGR (0.48) PTPN1MAPTMEN1KMT2ACYP1A2
SCHEMBL13882665 0.85 PGR (0.46) PTPN1MAPTMEN1KMT2ACYP1A2
SCHEMBL13882804 0.85 PGR (0.46) PTPN1MAPTMEN1KMT2ACYP1A2
SCHEMBL13882809 0.85 PGR (0.46) PTPN1MAPTMEN1KMT2ACYP1A2
SCHEMBL13882950 0.85 PGR (0.46) PTPN1MAPTMEN1KMT2ACYP1A2
SCHEMBL13882787 0.85 PGR (0.46) PTPN1MAPTMEN1KMT2ACYP1A2
SCHEMBL13883003 0.85 PGR (0.46) PTPN1MAPTMEN1KMT2ACYP1A2
SCHEMBL31478906 0.84 PTPN1 (0.43) PTPN1MAPTMEN1KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117567547-B Preparation method and application of indole diterpenoid compounds and derivatives thereof derived from endophytic fungi of schisandra chinensis 中国科学院昆明植物研究所 2025-03-28 CN claimed
CN-117567547-A Preparation method and application of indole diterpenoid compounds and derivatives thereof derived from endophytic fungi of schisandra chinensis 中国科学院昆明植物研究所 2024-02-20 CN claimed
US-20230145729-A1 INDOLE DITERPENE BIOSYNTHESIS GRASSLANZ TECHNOLOGY LIMITED (NZ) 2023-05-11 US claimed
EP-4125340-A1 INDOLE DITERPENE BIOSYNTHESIS Grasslanz Technology Limited (NZ) 2023-02-08 EP claimed
WO-2021201700-A1 INDOLE DITERPENE BIOSYNTHESIS GRASSLANZ TECHNOLOGY LIMITED (NZ) 2021-10-07 WO claimed
EP-3740063-A1 EPICHLOË ENDOPHYTE Grasslanz Technology Limited (NZ) 2020-11-25 EP claimed
WO-2019162816-A1 EPICHLOË ENDOPHYTE GRASSLANZ TECHNOLOGY LIMITED (NZ) 2019-08-29 WO claimed
EP-3162438-A1 POLYMER SUPPORTED VICINAL DIAMINES AND THEIR USE AS CATALYST IN THE HAJOS-PARRISH-ENDER-SAUSER-WIECHERT AND ROBINSON ANNULATION REACTIONS Fundació Institut Català d'Investigació Química (ES) 2017-05-03 EP claimed
US-20050239787-A1 Novel maxi-k channel blockers, methods of use and process for making the same MERCK & CO. INC. 2005-10-27 US claimed
EP-1515730-A4 NOVEL MAXI-K CHANNEL BLOCKERS, METHODS OF USE AND PROCESS FOR MAKING THE SAME MERCK & CO INC (US) 2005-07-20 EP claimed
EP-1515730-A1 NOVEL MAXI-K CHANNEL BLOCKERS, METHODS OF USE AND PROCESS FOR MAKING THE SAME Merck & Co., Inc. (US) 2005-03-23 EP claimed
WO-2003105868-A1 NOVEL MAXI-K CHANNEL BLOCKERS, METHODS OF USE AND PROCESS FOR MAKING THE SAME MERCK & CO., INC. (US) 2003-12-24 WO claimed
US-4973601-A METABOLITES CONTAINING INDOLE GROUP THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 1990-11-27 US claimed
CN-121204202-A Preparation method and application of insecticidal and antifeedant indole diterpenoid compound 中国科学院沈阳应用生态研究所 2025-12-26 CN disclosed
CN-121160824-A Preparation method and application of protein tyrosine phosphatase 1B inhibitory activity indole diterpenoid compound 中国科学院沈阳应用生态研究所 2025-12-19 CN disclosed
US-20250137015-A1 YEAST PLATFORM FOR RENEWABLE INDUSTRIAL TERPENE PRODUCTION Wang, Zhen (US) 2025-05-01 US disclosed
US-5227396-A Biodegradable insecticides from fungi THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 1993-07-13 US disclosed
WO-1993001721-A1 SULPININE, SECOPENITREM B AND AFLATREM B ANTIINSECTAN METABOLITES THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 1993-02-04 WO disclosed
US-5130326-A Plant extracts as insecticides THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 1992-07-14 US disclosed
US-4973601-A METABOLITES CONTAINING INDOLE GROUP THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 1990-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239787-A1 Novel maxi-k channel blockers, methods of use and process for making the same KCNJ11, KCNJ1, KCNJ2 PTPN1 4716/4885MAPT 1450/4885MEN1 189/4885
US-20230145729-A1 INDOLE DITERPENE BIOSYNTHESIS INMT, PNMT, COASY PTPN1 3891/4885MAPT 3924/4885MEN1 3622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.